← Reviews
Open accessFull analysisOct 29, 2026

Reproductive Tract Microbiome, Infertility, and ART: Comprehensive Narrative Review

This narrative review associates non-Lactobacillus-dominant endometrial profiles with worse implantation and ART outcomes, but establishes no causality and provides no quantified effect estimates.

Evidence levelDNarrative / animal / in vitro / mechanistic
Study typenarrative_review
Sample—
Effect directionInsufficient
CertaintyVery low
Clinical applicabilityVery low
Overinterpretation risk1/5 · Low
PICO
PopulationAdults with infertility or undergoing ART (IVF, ICSI, embryo transfer)
InterventionCharacterization of the female reproductive tract microbiome (vagina, cervix, endometrium, fallopian tubes) by 16S rRNA sequencing and NGS
ComparatorLactobacillus-dominant vs. non-Lactobacillus-dominant (NLD) profiles; fertile vs. infertile populations (when applicable)
OutcomeImplantation rate (Lactobacillus-dominant vs. NLD endometrium); Clinical pregnancy in ART cycles; Live birth rate in ART cycles; Recurrent implantation failure associated with NLD profile; Chronic endometritis associated with NLD microbiome; Vaginal CST I profile (L. crispatus) and reproductive environment; Efficacy of microbiome-based interventions (probiotics, antibiotics) in ART

Summary of findings

OutcomeEffect95% CICertaintyClinical relevanceNotes
Implantation rate (Lactobacillus-dominant vs. NLD endometrium)not reported (narrative review; in the pooled estimate)—Low—
Clinical pregnancy in ART cyclesnot reported (narrative review; in the pooled estimate)—Low—
Live birth rate in ART cyclesnot reported (narrative review; in the pooled estimate)—Low—
Recurrent implantation failure associated with NLD profilenot reported (narrative review; in the pooled estimate)—Low—
Chronic endometritis associated with NLD microbiomenot reported (narrative review; in the pooled estimate)—Low—
Vaginal CST I profile (L. crispatus) and reproductive environmentnot reported (narrative review; in the pooled estimate)—Low—
Efficacy of microbiome-based interventions (probiotics, antibiotics) in ARTnot reported (narrative review; in the pooled estimate)—Very low—

Context

Infertility affects approximately one in six adults globally and imposes substantial psychological, social, and financial burdens. The female reproductive tract microbiome has emerged as a potential modulator of endometrial receptivity and ART outcomes. The absence of quantitative synthesis and formal risk-of-bias assessment limits the practical conclusions of this review.

What the study showed

Included observational studies associate Lactobacillus-dominant endometrial profiles with higher implantation, clinical pregnancy, and live-birth rates in ART cycles; NLD profiles (enriched with Gardnerella, Prevotella, Atopobium) were associated with worse outcomes and chronic endometritis. No absolute numbers, relative risks, or confidence intervals were reported in the review for any outcome. Vaginal CST I (L. crispatus) is associated with a more favorable reproductive environment; CST IV is associated with bacterial vaginosis and, in some studies, implantation failure. The review acknowledges substantial heterogeneity among primary studies and lack of methodological standardization.

How it was done

Comprehensive narrative review; structured search of MEDLINE, Embase, and Web of Science from inception to March 2026. No protocol registration, no independent duplicate screening, no PRISMA, no formal risk-of-bias assessment (RoB 2, ROBINS-I, or AMSTAR-2), and no quantitative meta-analysis. Observational, interventional, and mechanistic human studies were included, along with systematic reviews and meta-analyses to identify primary literature.

Effect magnitude

No quantitative effect size estimates (RR, OR, SMD, MD) or confidence intervals were derived or synthesized in this review; the magnitude of effects described in primary studies cannot be extracted from this publication.

Risk of bias

Narrative design without a registered protocol, without risk-of-bias assessment (RoB 2/ROBINS-I/AMSTAR-2 not applied), and without quantitative synthesis precludes causal conclusions. Marked heterogeneity in primary studies — populations, sequencing platforms, microbial classifications, and outcome definitions — is acknowledged by the authors themselves. Selection bias in study inclusion and contamination in low-biomass samples (endometrium, fallopian tubes) are additional unquantified limitations.

Interpretation limit

What this study does NOT prove

This review does not prove causality between reproductive microbiome composition and infertility or ART failure. Findings are not generalizable to unstudied populations and do not support individualized therapeutic recommendations based on microbial profiles.

In clinical practice

Evidence is insufficient to recommend routine endometrial or vaginal microbiome screening before ART. Microbiome-based therapeutic approaches (probiotics, microbiota transplantation, targeted antibiotics) remain experimental and should not be incorporated into standard clinical protocols without support from RCTs with live-birth outcomes. Clinicians should treat established infections (bacterial vaginosis, chronic endometritis) according to current guidelines.

Limitations

Narrative design without a registered protocol, without risk-of-bias assessment (RoB 2/ROBINS-I/AMSTAR-2 not applied), and without quantitative synthesis precludes causal conclusions. Marked heterogeneity in primary studies — populations, sequencing platforms, microbial classifications, and outcome definitions — is acknowledged by the authors themselves. Selection bias in study inclusion and contamination in low-biomass samples (endometrium, fallopian tubes) are additional unquantified limitations.

What is still missing

Well-designed RCTs evaluating microbiome-directed interventions (probiotics, selective antibiotics) with live birth as the primary outcome in ART populations are needed. Standardization of sequencing methods, diagnostic thresholds, and dysbiosis criteria is a prerequisite for cross-study comparability.

Technical appendix

Version history

  • 1.0 · 2026-10-29 — Auto-generated under Evidence Standard v1.0

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.